Pancreas

Surgery, Endocopy, or Medicine for Chronic Pancreatitis?

Endoscopic therapy can be the best initial approach for patients with chronic pancreatitis, according to the July issue of Clinical Gastroenterology and Hepatology. Chronic pancreatitis is a progressive inflammatory disease characterized by abdominal pain and damage to endocrine and exocrine pancreatic tissue. Much of the pain results from intraductal hypertension, caused

Read more

What Causes Pancreatitis?

Trypsinogen might not be the sole culprit in acute pancreatitis, contradicting a century-old model of this disease; a new model is published in the December issue of Gastroenterology. Trypsinogen is a pancreatic protein that is converted in acinar cells to the enzyme trypsin—a protease that is important for digestion and

Read more

Do Stents Prevent Pancreatitis After ERCP?

Pancreatic duct stents reduce the incidence of pancreatitis following endoscopic retrograde cholangiopancreatography (ERCP), according to a study published in the October issue of Clinical Gastroenterology and Hepatology. Pancreatitis is the most common and potentially serious complication following ERCP, occurring in up to 9% of patients that receive this procedure and

Read more

Successful Surgery for Children with Chronic Pancreatitis

Total pancreatectomy, accompanied by auto-transplantation of islet cells, increases the quality of life for children with severe chronic pancreatitis, according to Melena Bellin et al. in the September issue of Clinical Gastroenterology and Hepatology. Chronic pancreatitis is rare among children, but is painful and progressive and can lead to narcotic

Read more

Fluid Resuscitation for Acute Pancreatitis—When and With What?

Patients that are given fluid resuscitation within 24 hours of developing acute pancreatitis are less likely to experience systemic inflammatory response (SIR) or organ failure, according to a study by Matthew G. Warndorf et al. in the August issue of Clinical Gastroenterology and Hepatology. Acute pancreatitis is an inflammatory process

Read more

Dangerous Diabetes Drugs?

The drugs sitagliptin and exenatide, used to treat patients with type 2 diabetes, increase risk for pancreatitis and cancer, according to a study from Michael Elashoff and colleagues published in the July issue of Gastroenterology. The authors examined the United States (US) Food and Drug Administration’s database of reported adverse

Read more

Tracking Pancreatic Cancer Cells

Tumors spread to other parts of the body when cancer cells can escape into the bloodstream, although it is not exactly clear how they enter the circulation or decide where to form new tumors. Andrew Rhim and colleagues at the University of Pennsylvania have developed a technology to label tumor

Read more

Which Patients with Cystic Fibrosis are at Greatest Risk for Pancreatitis?

Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) cause well-known lung defects, but in the January issue of Gastroenterology, Chee Y. Ooi et al. describe specific CFTR genotypes that increase risk for pancreatitis. Most patients with cystic fibrosis that carry mutations that severely disrupt CFTR function have a pancreatic

Read more

For Pancreatic Cysts—(Change in) Size Matters

The speed of cyst growth predicts whether branch duct intraductal papillary mucinous neoplasms (Br-IPMNs) will become malignant, according to a study by Mee Joo Kang et al. in the January issue of Clinical Gastroenterology and Hepatology. IPMN is a premalignant pancreatic lesion that progresses from adenoma to carcinoma; cysts are

Read more

How Prevalent are Pancreatic Cysts?

As more patients have undergone imaging examinations for various disorders, physicians have detected pancreatic cysts with increasing frequency. Some cysts become malignant yet many remain asymptomatic. However, the prevalence of pancreatic cysts among healthy individuals has not been established—it is important to determine how common these are, to devise strategies

Read more